• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Joint Disease Activity in Inflammatory Bowel Disease-associated Peripheral Spondyloarthritis Stratifies Therapeutic Response.

作者信息

Lai D, Funez-Depagnier G, Duenas-Bianchi L, Lavergne A, Battat R, Ahmed W, Schwartzman M, Lima S, Khan S, Chong P S, Sonnenberg G, Artis D, Lukin D, Scherl E, Longman R S

机构信息

Jill Roberts Center for IBD, Weill Cornell Medicine, New York, New York.

Division of Rheumatology, Hospital for Special Surgery, New York, New York.

出版信息

Gastro Hep Adv. 2022;1(2):137-140. doi: 10.1016/j.gastha.2021.12.002. Epub 2022 Feb 7.

DOI:10.1016/j.gastha.2021.12.002
PMID:35441160
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9015680/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e43/11308631/3d75acce0244/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e43/11308631/3d75acce0244/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e43/11308631/3d75acce0244/gr1.jpg

相似文献

1
Joint Disease Activity in Inflammatory Bowel Disease-associated Peripheral Spondyloarthritis Stratifies Therapeutic Response.炎症性肠病相关的外周型脊柱关节炎中的关节疾病活动度可分层治疗反应。
Gastro Hep Adv. 2022;1(2):137-140. doi: 10.1016/j.gastha.2021.12.002. Epub 2022 Feb 7.
2
Peripheral arthritis in patients with long-term inflammatory bowel disease. Results from 20 years of follow-up in the IBSEN study.长期炎症性肠病患者的外周关节炎。IBSEN研究20年随访结果。
Scand J Gastroenterol. 2018 Oct-Nov;53(10-11):1250-1256. doi: 10.1080/00365521.2018.1518482. Epub 2018 Oct 24.
3
Characterization and prevalence of spondyloarthritis and peripheral arthritis among patients with inflammatory bowel disease.炎症性肠病患者中脊柱关节炎和外周关节炎的特征及患病率
Clin Exp Gastroenterol. 2017 Sep 27;10:259-263. doi: 10.2147/CEG.S136383. eCollection 2017.
4
Biomarkers in Inflammatory Bowel Disease-Associated Spondyloarthritis: State of the Art and Unmet Needs.炎症性肠病相关脊柱关节炎的生物标志物：现状与未满足的需求。
J Immunol Res. 2019 May 30;2019:8630871. doi: 10.1155/2019/8630871. eCollection 2019.
5
The Effect of Vedolizumab on Spondyloarthritis Symptoms in a Cohort of Inflammatory Bowel Disease Patients.维多珠单抗对一组炎症性肠病患者脊柱关节炎症状的影响。
Eur J Rheumatol. 2023 Apr;10(2):50-56. doi: 10.5152/eurjrheum.2023.22049.
6
Classifying Back Pain and Peripheral Joint Complaints in Inflammatory Bowel Disease Patients: A Prospective Longitudinal Follow-up Study.炎症性肠病患者背痛和周围关节症状的分类：一项前瞻性纵向随访研究。
J Crohns Colitis. 2016 Feb;10(2):166-75. doi: 10.1093/ecco-jcc/jjv195. Epub 2015 Oct 28.
7
The joint-gut axis in inflammatory bowel diseases.炎症性肠病中的肠-肠轴。
J Crohns Colitis. 2010 Sep;4(3):257-68. doi: 10.1016/j.crohns.2009.11.005. Epub 2009 Nov 30.
8
Chronic bowel inflammation and inflammatory joint disease: Pathophysiology.慢性肠道炎症与炎性关节病：病理生理学
Joint Bone Spine. 2017 Jul;84(4):417-420. doi: 10.1016/j.jbspin.2016.12.016. Epub 2017 Jan 3.
9
Implementation of screening criteria for inflammatory bowel disease in patients with spondyloarthritis and its association with disease and endoscopic activity.炎症性肠病筛查标准在脊柱关节炎患者中的实施及其与疾病和内镜活动的关系。
Clin Rheumatol. 2023 Feb;42(2):415-422. doi: 10.1007/s10067-022-06297-7. Epub 2022 Sep 2.
10
Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients.肠病性关节炎患者采用多学科方法的影响。
Autoimmun Rev. 2016 Feb;15(2):184-90. doi: 10.1016/j.autrev.2015.11.002. Epub 2015 Nov 7.

引用本文的文献

1
Practical Tips for Diagnosis and Management of Concomitant Inflammatory Spondyloarthritis and Inflammatory Bowel Disease.合并炎症性脊柱关节炎和炎症性肠病的诊断与管理实用小贴士
Curr Gastroenterol Rep. 2025 Jul 14;27(1):52. doi: 10.1007/s11894-025-00990-8.
2
IgG-seq identifies immune-reactive enteric bacteria in Crohn's disease with spondyloarthritis.IgG测序可识别患有脊柱关节炎的克罗恩病患者体内具有免疫反应性的肠道细菌。
Gut Microbes. 2025 Dec;17(1):2464221. doi: 10.1080/19490976.2025.2464221. Epub 2025 Feb 13.
3
The gut microbiome regulates the clinical efficacy of sulfasalazine therapy for IBD-associated spondyloarthritis.

本文引用的文献

1
The impact of ustekinumab on extraintestinal manifestations of Crohn's disease: A post hoc analysis of the UNITI studies.乌司奴单抗对克罗恩病肠外表现的影响：UNITI 研究的事后分析。
United European Gastroenterol J. 2021 Jun;9(5):581-589. doi: 10.1002/ueg2.12094. Epub 2021 Jun 2.
2
Effects of ustekinumab on spondylitis-associated endpoints in TNFi-naïve active psoriatic arthritis patients with physician-reported spondylitis: pooled results from two phase 3, randomised, controlled trials.乌司奴单抗对 TNF 抑制剂初治活动性银屑病关节炎伴医生报告中脊柱关节炎患者的脊柱关节炎相关终点的影响：两项随机对照 3 期临床试验的汇总结果。
RMD Open. 2020 Feb;6(1). doi: 10.1136/rmdopen-2019-001149.
3
肠道微生物群调节柳氮磺胺吡啶治疗 IBD 相关脊柱关节炎的临床疗效。
Cell Rep Med. 2024 Mar 19;5(3):101431. doi: 10.1016/j.xcrm.2024.101431. Epub 2024 Feb 19.
Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial.
Guselkumab 在生物制剂初治的活动性银屑病关节炎患者中的疗效（DISCOVER-2）：一项双盲、随机、安慰剂对照的 3 期临床试验。
Lancet. 2020 Apr 4;395(10230):1126-1136. doi: 10.1016/S0140-6736(20)30263-4. Epub 2020 Mar 13.
4
2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.2019 年美国风湿病学会/脊柱关节炎协会/脊柱关节炎研究和治疗网络关于治疗强直性脊柱炎和非放射学中轴型脊柱关节炎的建议更新。
Arthritis Rheumatol. 2019 Oct;71(10):1599-1613. doi: 10.1002/art.41042. Epub 2019 Aug 22.
5
Three Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis.三项多中心、随机、双盲、安慰剂对照研究评估乌司奴单抗在中轴型脊柱关节炎中的疗效和安全性。
Arthritis Rheumatol. 2019 Feb;71(2):258-270. doi: 10.1002/art.40728. Epub 2018 Dec 29.
6
[Evaluation of performance of BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) in a Brazilian cohort of 1,492 patients with spondyloarthritis: data from the Brazilian Registry of Spondyloarthritides (RBE)].[巴西1492例脊柱关节炎患者队列中BASDAI（巴斯强直性脊柱炎疾病活动指数）的性能评估：来自巴西脊柱关节炎登记处（RBE）的数据]
Rev Bras Reumatol. 2015 Jan-Feb;55(1):48-54. doi: 10.1016/j.rbr.2014.05.005. Epub 2014 Oct 16.
7
Extraintestinal manifestations and complications in IBD.炎症性肠病的肠外表现和并发症。
Nat Rev Gastroenterol Hepatol. 2013 Oct;10(10):585-95. doi: 10.1038/nrgastro.2013.117. Epub 2013 Jul 9.
8
The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general.强直性脊柱炎国际评估协会分类标准：外周型脊柱关节炎和一般型脊柱关节炎。
Ann Rheum Dis. 2011 Jan;70(1):25-31. doi: 10.1136/ard.2010.133645. Epub 2010 Nov 24.
9
Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort.瑞士炎症性肠病队列中肠外表现的频率和危险因素。
Am J Gastroenterol. 2011 Jan;106(1):110-9. doi: 10.1038/ajg.2010.343. Epub 2010 Aug 31.
10
Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations.英夫利昔单抗治疗克罗恩病相关性脊柱关节病：一项关于诱导和维持肌肉骨骼及肠道症状缓解疗效的开放性研究
Ann Rheum Dis. 2004 Dec;63(12):1664-9. doi: 10.1136/ard.2003.012450. Epub 2004 Aug 5.